Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Loading Events

« All Events

OBN Science Social

February 12 @ 6:00 pm

Attendees will have the opportunity to engage with the Cancer Research Horizons Ventures team, a dedicated group of experts specialising in identifying and nurturing high-potential, oncology-focused ventures. This team plays a critical role in accelerating the development of early-stage biotech start-ups by providing not only funding but also strategic guidance and industry connections.

By working closely with visionary entrepreneurs, they aim to drive innovation in cancer treatment and technologies. In addition to managing the Cancer Research Horizons Seed Fund, they also support portfolio companies in areas such as business development, licensing, and commercialisation, ensuring these start-ups have the tools and resources to bring their groundbreaking solutions to market. This is an invaluable opportunity to connect with professionals at the forefront of cancer innovation, gain insights into the venture funding process, and explore potential partnerships that could shape the future of oncology.

Details

Date:
February 12
Time:
6:00 pm
Event Category:
Website:
https://obn.glueup.com/event/obn-science-social-stratford-london-112317/

Organiser

OBN
Go to Top